HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ECHA ‘Ignoring’ Law, Continues To OverREACH With Cosmetic Animal Tests – Cruelty Free International

Executive Summary

According to the NGO, not only are animals continuing to suffer in testing the Cosmetics Regulation’s animal-testing prohibitions were designed to eliminate, cruelty-free brands are having an increasingly difficult time avoiding animal-tested ingredients due to failings in the European Chemicals Agency’s administration of REACH.

You may also be interested in...

Cruelty Free Europe Grieves: ‘Very Little Left Now’ Of Cosmetic Animal-Testing Bans

The European Chemicals Agency's Board of Appeal finds that REACH requires ingredient registrants to perform animal studies, even if their substances are used exclusively in cosmetic products. Historically opposed industry and animal welfare groups both may lose under the board’s decisions.

ECHA Releases Fourth Non-Animal Methods Report; ‘A Bricked-Up Window,’ Says PETA UK

Animal-welfare groups have been critical of the European Chemicals Agency's administration of REACH's "last resort" principle. PETA UK says the agency's latest report to the European Commission on registrants' use of alternative, non-animal methods similarly comes up short.

ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts